CA

CanBas Co.,Ltd.

4575 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
沼津市大手町二丁目2番1号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CanBas Co., Ltd. is an innovative bioventure company based in Japan, specializing in the research and development of novel cancer therapies. With a commitment to advancing cancer treatment, CanBas focuses on creating effective chemotherapeutic agents aimed at improving patient outcomes. The company emphasizes transparency and engagement, regularly sharing insights through management blogs that provide updates beyond standard disclosures. CanBas is dedicated to its mission of pioneering breakthroughs in cancer medicine, guided by a strong management team and a robust corporate ethos.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for CanBas Co.,Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-02-13 07:55
Regulatory News Service
確認書
Japanese 8.1 KB
2025-02-13 07:54
Interim Report
半期報告書-第26期(2024/07/01-2025/06/30)
Japanese 160.4 KB
2024-09-30 08:04
Regulatory News Service
臨時報告書
Japanese 22.7 KB
2024-09-27 08:21
Regulatory News Service
内部統制報告書-第25期(2023/07/01-2024/06/30)
Japanese 21.7 KB
2024-09-27 08:21
Regulatory News Service
確認書
Japanese 8.1 KB
2024-09-27 08:20
Annual Report
有価証券報告書-第25期(2023/07/01-2024/06/30)
Japanese 637.2 KB
2024-05-10 08:16
Regulatory News Service
確認書
Japanese 8.1 KB
2024-05-10 08:16
Quarterly Report
四半期報告書-第25期第3四半期(2024/01/01-2024/03/31)
Japanese 134.6 KB
2024-02-09 08:13
Regulatory News Service
確認書
Japanese 8.0 KB
2024-02-09 08:12
Quarterly Report
四半期報告書-第25期第2四半期(2023/10/01-2023/12/31)
Japanese 163.0 KB
2023-11-10 08:00
Regulatory News Service
確認書
Japanese 8.0 KB
2023-11-10 07:51
Quarterly Report
四半期報告書-第25期第1四半期(2023/07/01-2023/09/30)
Japanese 134.0 KB
2023-09-27 08:08
Regulatory News Service
臨時報告書
Japanese 22.4 KB
2023-09-26 08:07
Regulatory News Service
内部統制報告書-第24期(2023/09/25-2023/09/25)
Japanese 21.7 KB
2023-09-26 08:06
Regulatory News Service
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all CanBas Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CanBas Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK